AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery
Iambic official newsroom · 行業原文收錄 · 來源發佈：Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 09:08:23 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
− Multi-year partnership applies Iambic’s AI platform to speed up small molecule drug discovery in immunology, neuroscience and oncology − Companies to pursue programs with both first-in-class and best-in-class potential, combining Iambic’s molecular superintelligence platform with AbbVie’s therapeutic area expertise NORTH CHICAGO, Ill., and SAN DIEGO, Sept. 21, 2026 – AbbVie (NYSE: ABBV) and Iamb
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。